Clinical Trial Update: A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ENIA11 for ankylosing spondylitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• ENIA11

Snippet

Sponsor: Mycenax Biotech Inc. | Conditions: Ankylosing Spondylitis | Phase 3 | Status: TERMINATED